What were the results of the ISAR-TRIPLE study?
The primary end point (composite of death, MI, definite stent thrombosis, stroke, or Thrombolysis In Myocardial Infarction major bleeding at 9 months) occurred in 30 patients (9.8%) in the 6-week group compared with 27 patients (8.8%) in the 6-month group (HR, 1.14; 95% CI, 0.68-1.91; P .63). There were no significant differences for the secondary combined ischemic end point of cardiac death, MI, definite stent thrombosis, and 95% CI, 0.43-2.05; P .87) or the secondary bleeding end point of Thrombolysis In Myocardial Infarction 95% CI, 0.64-2.84; P .44).